首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3347951篇
  免费   272481篇
  国内免费   5995篇
耳鼻咽喉   48483篇
儿科学   107246篇
妇产科学   93022篇
基础医学   470966篇
口腔科学   99329篇
临床医学   304807篇
内科学   647027篇
皮肤病学   70273篇
神经病学   278581篇
特种医学   134151篇
外国民族医学   1247篇
外科学   505464篇
综合类   82822篇
现状与发展   4篇
一般理论   1426篇
预防医学   270101篇
眼科学   79518篇
药学   251600篇
  6篇
中国医学   6080篇
肿瘤学   174274篇
  2018年   33602篇
  2016年   28892篇
  2015年   33032篇
  2014年   46909篇
  2013年   71740篇
  2012年   96433篇
  2011年   101994篇
  2010年   60263篇
  2009年   57531篇
  2008年   97123篇
  2007年   102871篇
  2006年   104032篇
  2005年   101168篇
  2004年   98195篇
  2003年   94393篇
  2002年   93088篇
  2001年   153280篇
  2000年   158566篇
  1999年   134049篇
  1998年   36771篇
  1997年   33116篇
  1996年   32592篇
  1995年   33725篇
  1994年   31729篇
  1993年   29689篇
  1992年   109518篇
  1991年   106029篇
  1990年   102894篇
  1989年   99388篇
  1988年   92355篇
  1987年   91143篇
  1986年   86558篇
  1985年   83006篇
  1984年   62886篇
  1983年   53924篇
  1982年   32527篇
  1981年   29020篇
  1980年   27323篇
  1979年   59724篇
  1978年   41981篇
  1977年   35369篇
  1976年   33196篇
  1975年   35158篇
  1974年   43411篇
  1973年   41484篇
  1972年   38672篇
  1971年   36005篇
  1970年   33601篇
  1969年   31376篇
  1968年   28623篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
Journal of Thrombosis and Thrombolysis - Alteplase treatment can cause a systemic coagulopathy although the incidence and contributory factors are unknown in pulmonary embolism (PE). Fixed-dosing...  相似文献   
74.
BackgroundWhile studies have demonstrated favorable outcomes in utilization of primary total shoulder arthroplasty (TSA) for the treatment of glenohumeral osteoarthritis (OA), adverse events such as infections can still occur. Periprosthetic joint infections (PJIs) are associated with worse outcomes and patient morbidity. The purpose of this study was to: (1) compare patient demographics amongst TSA patients with and without PJIs following primary TSA; and (2) identify patient-related risk factors for PJIs following primary TSA.MethodsPatients undergoing primary TSA for the treatment of glenohumeral OA were identified using the Mariner administrative claims database by CPT code 23,472. Laterality modifiers were utilized to ensure PJIs were developing in the correct laterality as those patients undergoing primary TSA. Inclusion for the study group consisted of patients who developed PJIs within 2-years after the index procedure, whereas patients who did not develop PJIs served as the comparison cohort. Primary outcomes analyzed included patient demographics and patient-related risk factors for PJIs following primary TSA. A stepwise backwards elimination multivariate binomial logistic regression analyses was performed to determine the odds (OR) of PJIs in patients undergoing primary TSA. A P value less than .05 was considered statistically significant.ResultsThe query yielded 15,396 patients who underwent primary TSA for glenohumeral OA, of which 191 patients developed PJIs and 15,205 did not develop PJIs. The study found statistically significant differences amongst patients who did and did not develop PJIs following primary TSA with respect to age, sex, and presence of comorbid conditions. Risk factors associated with developing PJIs following primary TSA included: pathologic weight loss (OR: 2.06, P < .0001), obesity (OR: 1.56, P = .0001), male sex (OR: 1.52, P = .007), and peripheral vascular disease (OR: 1.46, P = .022).ConclusionAs the number of primary TSAs for the treatment of glenohumeral OA increase worldwide, identifying modifiable risk-factors to reduce the incidence of infection is critical. The study found various modifiable and non-modifiable risk factors associated with developing PJIs following primary TSA. This study is valuable to orthopedists in order to identify and risk-stratify patients with regard to PJI in the setting of primary TSA for OA.Level of EvidenceLevel III; Case-Control Study  相似文献   
75.
76.
In 2019, the scientists who discovered how cells sense and adapt to oxygen availability were awarded the Nobel Prize. This elegant sensing pathway is conserved throughout evolution, and it underpins the physiology and pathology that we, as clinicians in anaesthesia and critical care, encounter on a daily basis. The purpose of this review is to bring hypoxia-inducible factor, and the oxygen-sensing pathway as a whole, to the wider clinical community. We describe how this unifying mechanism was discovered, and how it orchestrates diverse changes such as erythropoiesis, ventilatory acclimatisation, pulmonary vascular remodelling and altered metabolism. We explore the lessons learnt from genetic disorders of oxygen sensing, and the wider implications in evolution of all animal species, including our own. Finally, we explain how this pathway is relevant to our clinical practice, and how it is being manipulated in new treatments for conditions such as cancer, anaemia and pulmonary hypertension.  相似文献   
77.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
78.
79.
80.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号